Fig. 2From: Estimating and visualising the trade-off between benefits and harms on multiple clinical outcomes in network meta-analysis\({SAWIS}_{i}\) quantity for the network of antipsychotics for the acute treatment of multi-episode schizophrenia. The benefit spie chart included only one efficacy outcome, overall symptoms of schizophrenia, and the harm spie chart included antiparkinson medication use, weight gain, prolactin elevation, and QTc prolongation with weights 0.4, 0.3, 0.15, and 0.15, respectivelyBack to article page